Variant report
Variant | esv3340260 |
---|---|
Chromosome Location | chr4:100341229-100345527 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs139901645 | chr4:100341259-100341260 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs549081396 | chr4:100341264-100341265 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs543033795 | chr4:100341285-100341286 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs572306870 | chr4:100341288-100341289 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs141731063 | chr4:100341332-100341333 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs547849585 | chr4:100341341-100341342 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs144563947 | chr4:100341350-100341351 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs531589723 | chr4:100341380-100341381 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs930478 | chr4:100341381-100341382 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs562634057 | chr4:100341421-100341422 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs530047073 | chr4:100341427-100341428 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs189500307 | chr4:100341436-100341437 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs148428639 | chr4:100341443-100341444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs533994514 | chr4:100341479-100341480 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs192400140 | chr4:100341506-100341507 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs142585452 | chr4:100341517-100341518 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs150920714 | chr4:100341523-100341524 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs549795487 | chr4:100341549-100341550 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs184607157 | chr4:100341567-100341568 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs371943586 | chr4:100341580-100341581 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs553685168 | chr4:100341600-100341601 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs1154460 | chr4:100341643-100341644 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
23 | rs371817232 | chr4:100341658-100341659 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs572269923 | chr4:100341666-100341667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs375206978 | chr4:100341668-100341669 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs200563530 | chr4:100341671-100341672 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs202189094 | chr4:100341681-100341682 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs369188890 | chr4:100341683-100341684 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs201718372 | chr4:100341684-100341685 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs199514167 | chr4:100341686-100341687 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs199972891 | chr4:100341691-100341692 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs139516819 | chr4:100341705-100341706 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs374938260 | chr4:100341732-100341733 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs143235779 | chr4:100341739-100341740 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs566626823 | chr4:100341740-100341741 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs576525742 | chr4:100341742-100341743 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs368178823 | chr4:100341782-100341783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs375067624 | chr4:100341783-100341784 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs543439973 | chr4:100341787-100341788 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs146193104 | chr4:100341788-100341789 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs189036180 | chr4:100341798-100341799 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs139072684 | chr4:100341809-100341810 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs113993320 | chr4:100341818-100341819 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs368994439 | chr4:100341822-100341823 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs59534319 | chr4:100341839-100341840 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs148997247 | chr4:100341846-100341847 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs142925993 | chr4:100341856-100341857 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs971074 | chr4:100341861-100341862 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundancedisease |
49 | rs372637703 | chr4:100341904-100341905 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs377699817 | chr4:100341926-100341927 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 16573809 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Melanoma | 20688739 | CNVD |
Gastric cancer | 16891809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:100332000-100353400 | Weak transcription | Esophagus | oesophagus |
2 | chr4:100341800-100342000 | Enhancers | Gastric | stomach |